![Norman LaFrance](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Norman LaFrance
Corporate Officer/Principal chez
YMAS THER
Profil
Norman D.
LaFrance is currently Chief Development Officer at Y-mAbs Therapeutics, Inc. since 2024.
Former positions include Chief Medical Officer & Senior Vice President at Plus Therapeutics, Inc. from 2021 to 2024; Chief Medical Officer & Senior Vice President at Jubilant Pharma Ltd. from 2012 to 2022; Global Chief Medical Officer at Zevacor Pharma, Inc. from 2010 to 2012; Chief Medical Officer & SVP-Clinical Development at Molecular Insight Pharmaceuticals, Inc. from 2007 to 2010; VP-Global Pharmaceutical Research & Development at Bausch & Lomb, Inc. from 2005 to 2007; and Senior Vice President-Medical & Regulatory Affairs at Celltech Americas, Inc. from 2002 to 2005.
Education includes undergraduate and graduate degrees from Rensselaer Polytechnic Institute and a doctorate from the University of Arizona.
Postes actifs de Norman LaFrance
| Sociétés | Poste | Début |
|---|---|---|
| YMAS THER | Corporate Officer/Principal | 05/06/2024 |
Anciens postes connus de Norman LaFrance
| Sociétés | Poste | Fin |
|---|---|---|
| CERENOME, INC. | Directeur Technique/Scientifique/R&D | 11/06/2024 |
Jubilant Pharma Ltd.
 Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2022 |
Jubilant Pharma Holdings, Inc.
 Jubilant Pharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur Technique/Scientifique/R&D | 01/11/2021 |
Zevacor Pharma, Inc.
 Zevacor Pharma, Inc. Medical DistributorsDistribution Services Distributes and develops molecular imaging solutions | Directeur Technique/Scientifique/R&D | 01/01/2012 |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Directeur Technique/Scientifique/R&D | 05/11/2010 |
Formation de Norman LaFrance
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Health Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Celltech Americas, Inc. | |
Zevacor Pharma, Inc.
Zevacor Pharma, Inc. Medical DistributorsDistribution Services Distributes and develops molecular imaging solutions | Distribution Services |
Jubilant Pharma Ltd.
Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Jubilant Pharma Holdings, Inc.
Jubilant Pharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
